Dose Per Fraction Calculator
Estimate dose per fraction, BED (Biologically Effective Dose), EQD2, and treatment intensity from a prescribed plan. This calculator is for education and planning support only and does not replace physician judgment.
Expert Guide: How to Use a Dose Per Fraction Calculator Correctly
A dose per fraction calculator helps clinicians, students, and informed patients understand how a total radiation prescription is split across treatment sessions and how that split affects biological impact. In external beam radiation therapy, the same total physical dose can behave differently depending on the number of fractions and the dose delivered each day. That is the key reason fractionation remains one of the most important ideas in clinical radiobiology.
At a basic level, dose per fraction is a simple arithmetic value: total prescribed dose divided by number of fractions. However, clinical interpretation goes beyond this simple number. The relationship between fraction size and tissue effect is nonlinear. This is why many teams also calculate BED (Biologically Effective Dose) and EQD2 (Equivalent Dose in 2 Gy fractions). BED and EQD2 help compare regimens that use different schedules, including conventional fractionation, moderate hypofractionation, and ultra-hypofractionation.
This page is designed to be practical: you enter total dose, fractions, and an alpha/beta ratio, then the calculator reports dose per fraction, BED, EQD2, and optional dose intensity if total treatment days are supplied. These outputs can support plan comparison, chart checks, educational review, and communication among multidisciplinary teams.
Why Dose Per Fraction Matters in Clinical Practice
Fractionation balances tumor control probability and normal tissue complication probability. Delivering treatment in fractions allows repair of sublethal damage in normal tissues between sessions while still producing cumulative tumor cell kill. If fraction size increases too much for a given tissue, late toxicity risk can rise. If fraction size is too low in some settings, treatment efficiency or local control may be less favorable than modern alternatives.
- Conventional schedules often use around 1.8 to 2.0 Gy per fraction.
- Moderate hypofractionation commonly uses roughly 2.4 to 3.4 Gy per fraction.
- Ultra-hypofractionation/SBRT may use 5 Gy or much higher per fraction, depending on site and protocol.
For plan review, the dose per fraction alone is informative, but BED and EQD2 give additional context for biological equivalence. This is especially useful when comparing protocols across institutions or evaluating whether two regimens are roughly comparable for a specific alpha/beta assumption.
Core Equations Used by This Calculator
The calculator uses the standard linear-quadratic framework:
- Dose per fraction (d) = Total dose (D) / Number of fractions (n)
- BED = nd[1 + d/(alpha/beta)]
- EQD2 = BED / [1 + 2/(alpha/beta)]
The alpha/beta ratio reflects how sensitive tissue response is to fraction size. A higher alpha/beta value usually means less sensitivity to changes in fraction size (typical for many early-responding tissues and many tumors), while lower alpha/beta values usually indicate greater fraction-size sensitivity (often associated with late effects in normal tissues and specific tumors such as prostate adenocarcinoma in many models).
Step-by-Step Use of the Calculator
- Enter the total prescribed dose in Gy.
- Enter the number of fractions.
- Select an alpha/beta preset or choose custom.
- If needed, provide overall elapsed treatment days to estimate average dose intensity.
- Click Calculate to generate outputs and chart visualization.
The results section shows key values in a compact format. The chart gives a quick visual comparison between total dose, per-fraction dose, BED, and EQD2 so users can rapidly compare regimens side by side when running repeated calculations.
Comparison Table: Well-Known Fractionation Trials and Reported Outcomes
The table below summarizes selected published trial results frequently cited in discussions of fractionation. Statistics are shown in concise form for educational comparison and should always be interpreted in full trial context, including endpoints, follow-up duration, eligibility criteria, and toxicity methodology.
| Trial / Disease Site | Regimens Compared | Key Reported Efficacy Statistic | Practical Fractionation Takeaway |
|---|---|---|---|
| FAST-Forward (breast) | 26 Gy/5 fractions vs 40 Gy/15 fractions | 5-year ipsilateral breast tumor relapse: approximately 2.1% in both groups | Supports appropriately selected 1-week breast schedules in many early breast settings. |
| START-B (breast) | 40 Gy/15 fractions vs 50 Gy/25 fractions | 10-year local-regional relapse around 4.3% vs 5.5% (reported comparisons favored 40/15 in many analyses) | Moderate hypofractionation became a standard foundation for many adjuvant breast protocols. |
| CHHiP (prostate) | 60 Gy/20 fractions vs 74 Gy/37 fractions | 5-year biochemical/clinical control outcomes reported as non-inferior for 60/20 schedule | Moderate hypofractionation is widely used in localized prostate cancer treatment pathways. |
Comparison Table: Example BED and EQD2 Across Common Schedules
To illustrate how biological interpretation changes with fraction size, the table below uses the same formulas embedded in this calculator. Values are rounded examples and assume an alpha/beta of 3 Gy (late responding tissue model).
| Schedule | Dose/Fraction | BED (alpha/beta = 3) | EQD2 (alpha/beta = 3) | Interpretive Note |
|---|---|---|---|---|
| 50 Gy in 25 fractions | 2.00 Gy | 83.3 Gy | 50.0 Gy | Reference-like conventional fractionation benchmark. |
| 40 Gy in 15 fractions | 2.67 Gy | 75.6 Gy | 45.3 Gy | Lower EQD2 for late effects model, often acceptable by site-specific evidence. |
| 60 Gy in 20 fractions | 3.00 Gy | 120.0 Gy | 72.0 Gy | Higher biologic dose under low alpha/beta assumptions. |
| 26 Gy in 5 fractions | 5.20 Gy | 71.1 Gy | 42.7 Gy | Very large fraction size; protocol details and constraints are critical. |
How to Choose the Right Alpha/Beta Input
One of the most important judgment steps in using a dose per fraction calculator is selecting the alpha/beta ratio. There is no single universal value that fits every tumor subtype or every normal tissue endpoint. Instead, teams use ranges informed by literature, site-specific protocols, and institutional experience. If your center has a protocol value, use that value first for consistency.
- 10 Gy preset: common educational default for many tumors and early effects modeling.
- 3 Gy preset: common modeling value for late responding normal tissues.
- 1.5 Gy preset: often discussed in prostate fractionation literature.
If you are comparing regimens, consider recalculating with more than one plausible alpha/beta value. Doing this sensitivity check can reveal whether your conclusion is stable or heavily dependent on a single assumption.
Clinical Interpretation Tips and Safety Notes
- Use this calculator to support discussion, not to bypass physician-approved planning workflow.
- Always interpret BED and EQD2 with contour quality, image guidance, setup uncertainty, and OAR constraints.
- Do not compare regimens only by BED when major differences exist in fraction spacing, technique, or target volume coverage.
- Consider total treatment time effects and potential repopulation in rapidly proliferating tumors.
- For SBRT and high-dose-per-fraction regimens, linear-quadratic extrapolation at extreme doses should be interpreted carefully.
Quality Assurance Checklist Before You Trust a Number
- Verify total dose and fraction count against the signed prescription.
- Confirm units are in Gy, not cGy.
- Check whether the schedule includes planned breaks or split courses.
- Use the intended alpha/beta model from protocol guidance.
- Cross-check output with a second method or independent tool for high-stakes decisions.
Important: BED and EQD2 are modeling tools. They are valuable for comparison, but they are not substitutes for patient-specific plan optimization, organ-at-risk dose constraints, toxicity risk assessment, and multidisciplinary review.
Authoritative Resources for Deeper Reading
For evidence-based background and patient-facing information, review these authoritative references:
- National Cancer Institute (.gov): Radiation Therapy Overview
- NCBI Bookshelf (.gov): Radiobiology and Fractionation Concepts
- SEER Program (.gov): U.S. Cancer Statistics and Context
Final Perspective
A high-quality dose per fraction calculator turns abstract radiobiology into clear, usable numbers. In modern oncology, that clarity helps teams compare regimens, educate trainees, and communicate with patients in a transparent way. Still, good decisions come from combining these calculations with clinical evidence, contouring standards, image guidance quality, and individualized risk-benefit assessment. Use this tool as part of a structured decision process, not as a standalone endpoint.